176 related articles for article (PubMed ID: 36274154)
1. Bile acid distributions, sex-specificity, and prognosis in colorectal cancer.
Cai Y; Shen X; Lu L; Yan H; Huang H; Gaule P; Muca E; Theriot CM; Rattray Z; Rattray NJW; Lu J; Ahuja N; Zhang Y; Paty PB; Khan SA; Johnson CH
Biol Sex Differ; 2022 Oct; 13(1):61. PubMed ID: 36274154
[TBL] [Abstract][Full Text] [Related]
2. Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in the colon.
Bazzoli F; Fromm H; Sarva RP; Sembrat RF; Ceryak S
Gastroenterology; 1982 Oct; 83(4):753-60. PubMed ID: 7106506
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid, 7-ketolithocholic acid, and chenodeoxycholic acid are primary bile acids of the nutria (Myocastor coypus).
Tint GS; Bullock J; Batta AK; Shefer S; Salen G
Gastroenterology; 1986 Mar; 90(3):702-9. PubMed ID: 3943698
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid, chenodeoxycholic acid, and 7-ketolithocholic acid are primary bile acids of the guinea pig.
Tint GS; Xu GR; Batta AK; Shefer S; Niemann W; Salen G
J Lipid Res; 1990 Jul; 31(7):1301-6. PubMed ID: 2401860
[TBL] [Abstract][Full Text] [Related]
5. Conversion of 7-ketolithocholic acid to ursodeoxycholic acid by human intestinal anaerobic microorganisms: interchangeability of chenodeoxycholic acid and ursodeoxycholic acid.
Higashi S; Setoguchi T; Katsuki T
Gastroenterol Jpn; 1979 Oct; 14(5):417-24. PubMed ID: 520764
[TBL] [Abstract][Full Text] [Related]
6. Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid.
Salen G; Tint GS; Eliav B; Deering N; Mosbach EH
J Clin Invest; 1974 Feb; 53(2):612-21. PubMed ID: 11344576
[TBL] [Abstract][Full Text] [Related]
7. Transformation of chenodeoxycholic acid to ursodeoxycholic acid in patients with Crohn's disease.
Miwa H; Yamamoto M; Nishida T; Yao T
Gastroenterology; 1986 Mar; 90(3):718-23. PubMed ID: 3943699
[TBL] [Abstract][Full Text] [Related]
8. Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria.
Fedorowski T; Salen G; Tint GS; Mosbach E
Gastroenterology; 1979 Nov; 77(5):1068-73. PubMed ID: 488633
[TBL] [Abstract][Full Text] [Related]
9. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
[TBL] [Abstract][Full Text] [Related]
10. Absorption of 7-ketolithocholic acid in rat jejunum, ileum and colon.
Walker S; Stiehl A; Raedsch R; Klöters P; Kommerell B
Z Gastroenterol; 1985 Dec; 23(12):681-3. PubMed ID: 4090568
[TBL] [Abstract][Full Text] [Related]
11. Differing effect of chenodeoxycholic acid and ursodeoxycholic acid on bile acids in rat colonic wall and contents.
Kurtz WJ; Guldutuna S; Leuschner U
Tokai J Exp Clin Med; 1988 Jun; 13(2):91-7. PubMed ID: 3250006
[TBL] [Abstract][Full Text] [Related]
12. Ileal and colonic mucosal bile acids in Crohn's disease and right colonic carcinoma.
Kurtz WJ; Leuschner U; Strohm WD; Classen M
Tokai J Exp Clin Med; 1985 Apr; 10(1):47-50. PubMed ID: 4095712
[TBL] [Abstract][Full Text] [Related]
13. The mutagenicity of bile acids using a fluctuation test.
Watabe J; Bernstein H
Mutat Res; 1985; 158(1-2):45-51. PubMed ID: 2995801
[TBL] [Abstract][Full Text] [Related]
14. pH-Solubility relations of chenodeoxycholic and ursodeoxycholic acids: physical-chemical basis for dissimilar solution and membrane phenomena.
Igimi H; Carey MC
J Lipid Res; 1980 Jan; 21(1):72-90. PubMed ID: 7354256
[TBL] [Abstract][Full Text] [Related]
15. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
[TBL] [Abstract][Full Text] [Related]
16. Oral gavage of nano-encapsulated conjugated acrylic acid-bile acid formulation in type 1 diabetes altered pharmacological profile of bile acids, and improved glycaemia and suppressed inflammation.
Mooranian A; Zamani N; Ionescu CM; Takechi R; Luna G; Mikov M; Goločorbin-Kon S; Kovačević B; Al-Salami H
Pharmacol Rep; 2020 Apr; 72(2):368-378. PubMed ID: 32048259
[TBL] [Abstract][Full Text] [Related]
17. Bile acids in bile during long-term chenodeoxycholic acid treatment.
Bremmelgaard A; Pedersen L
Scand J Gastroenterol; 1976; 11(2):161-5. PubMed ID: 1265436
[TBL] [Abstract][Full Text] [Related]
18. Morphologic changes in livers of hamsters treated with high doses of ursodeoxycholic acid: correlation with bile acids in bile.
Mamianetti A; Konopka HF; Lago N; Vescina C; Scarlato E; Carducci CN
Pharmacol Res; 1994; 29(2):187-95. PubMed ID: 8058592
[TBL] [Abstract][Full Text] [Related]
19. Value of serum determinations for prediction of increased ursodeoxycholic and chenodeoxycholic levels in bile.
Bazzoli F; Fromm H; Roda A; Tunuguntla AK; Roda E; Barbara L; Amin P
Dig Dis Sci; 1985 Jul; 30(7):650-4. PubMed ID: 4006647
[TBL] [Abstract][Full Text] [Related]
20. Antral mucosal bile acids in two types of chronic atrophic gastritis.
Kurtz WJ; Dikimli A; Leuschner U; Classen M
Tokai J Exp Clin Med; 1988 Feb; 13(1):31-6. PubMed ID: 3232160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
